Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Yair Lotan

Urology
UT Southwestern Medical Center
University Of Texas Southwestern Medical Center At Dallas
12500 Dallas Pkwy, 
Frisco, TX 
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
UT Southwestern Medical Center
University Of Texas Southwestern Medical Center At Dallas
12500 Dallas Pkwy, 
Frisco, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yair Lotan is an Urologist in Frisco, Texas. Dr. Lotan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.

His clinical research consists of co-authoring 596 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in TX
Hospital Affiliations
Parkland Health & Hospital System
Jps Health Network
UT Of Texas Southwestern University Hospital - William P. Clements Jr.
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
12500 Dallas Pkwy, Frisco, TX 75033
Call: 469-604-9000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design (STRATA Study)
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design (STRATA Study)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2025
Intervention Type: Procedure, Other
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
Enrollment Status: Terminated
Publish Date: June 06, 2024
Intervention Type: Drug, Procedure
Study Drug: Mitomycin C
Study Phase: Phase 3
Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer
Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Device
Multi Institutional Study To Evaluate Dna Methlyation Markers For Detection Of Primary Bladder Cancer In Urine Samples From A Cohort Of Patients With Hematuria
Multi Institutional Study To Evaluate Dna Methlyation Markers For Detection Of Primary Bladder Cancer In Urine Samples From A Cohort Of Patients With Hematuria
Enrollment Status: Unknown
Publish Date: March 06, 2019
Intervention Type: Diagnostic test
View 6 Less Clinical Trials

596 Total Publications

Erratum: TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.
Erratum: TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 09, 2025
View All 596 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jeffrey A. Cadeddu
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jeffrey A. Cadeddu
Urology

University Of Texas Southwestern Medical Center At Dallas

5323 Harry Hines Blvd, 
Dallas, TX 
 (25.3 miles away)
214-645-8200
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jeffrey Cadeddu is an Urologist in Dallas, Texas. Dr. Cadeddu is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), UPJ Obstruction, Prostate Cancer, Nephrectomy, and Endoscopy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Vitaly Margulis
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Vitaly Margulis
Urology

University Of Texas Southwestern Medical Center At Dallas

1500 S Main St Opc 2nd Floor, Urology, 
Fort Worth, TX 
 (41.7 miles away)
817-702-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vitaly Margulis is an Urologist in Fort Worth, Texas. Dr. Margulis is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Orchiectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Harrison M. Abrahams
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Harrison M. Abrahams
Urology

Urology Partners Of North Texas, PLLC

1901 N Macarthur Blvd, Baylor Medical Center At I, 
Irving, TX 
 (24.8 miles away)
972-579-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Harrison Abrahams is an Urologist in Irving, Texas. Dr. Abrahams is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Wilms Tumor, Clear Cell Sarcoma, Renal Cell Carcinoma (RCC), Reconstructive Urology Surgery, and Nephrectomy. Dr. Abrahams is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lotan's expertise for a condition
ConditionClose
  • Elite
  • Bladder Cancer
    Dr. Lotan is
    Elite
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Cystectomy
    Dr. Lotan is
    Elite
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Hydronephrosis
    Dr. Lotan is
    Elite
    . Learn about Hydronephrosis.
    See more Hydronephrosis experts
  • Muscle Invasive Bladder Cancer
    Dr. Lotan is
    Elite
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Nephrectomy
    Dr. Lotan is
    Elite
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Lotan is
    Elite
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
View All 10 Elite Conditions
  • Distinguished
  • Chromophobe Renal Cell Carcinoma
    Dr. Lotan is
    Distinguished
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Lotan is
    Distinguished
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Endoscopy
    Dr. Lotan is
    Distinguished
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Familial Prostate Cancer
    Dr. Lotan is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Familial Wilms Tumor 2
    Dr. Lotan is
    Distinguished
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Lithotripsy
    Dr. Lotan is
    Distinguished
    . Learn about Lithotripsy.
    See more Lithotripsy experts
View All 14 Distinguished Conditions
  • Advanced
  • Bilateral Hydronephrosis
    Dr. Lotan is
    Advanced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Stones
    Dr. Lotan is
    Advanced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Boils
    Dr. Lotan is
    Advanced
    . Learn about Boils.
    See more Boils experts
  • Carbuncle
    Dr. Lotan is
    Advanced
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Enlarged Prostate (BPH)
    Dr. Lotan is
    Advanced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
  • Folliculitis
    Dr. Lotan is
    Advanced
    . Learn about Folliculitis.
    See more Folliculitis experts
View All 20 Advanced Conditions
  • Experienced
  • Autosomal Dominant Polycystic Kidney Disease
    Dr. Lotan is
    Experienced
    . Learn about Autosomal Dominant Polycystic Kidney Disease.
    See more Autosomal Dominant Polycystic Kidney Disease experts
  • Bladder Outlet Obstruction
    Dr. Lotan is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Choriocarcinoma
    Dr. Lotan is
    Experienced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
  • Empyema
    Dr. Lotan is
    Experienced
    . Learn about Empyema.
    See more Empyema experts
  • Eosinophilic Cystitis
    Dr. Lotan is
    Experienced
    . Learn about Eosinophilic Cystitis.
    See more Eosinophilic Cystitis experts
  • Eunuchoidism Familial Hypogonadotropic
    Dr. Lotan is
    Experienced
    . Learn about Eunuchoidism Familial Hypogonadotropic.
    See more Eunuchoidism Familial Hypogonadotropic experts
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved